Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
Revolution Medicines’ Acquisition of EQRx
SMART Global Holdings’ Acquisition of Stratus Technologies
Latham & Watkins represented SGH in the transaction while Sidley advised SMART Global Holdings. SMART Global Holdings, Inc. (SGH) (Nasdaq: SGH) has entered into a definitive agreement with...
SourceDay’s $31.5 Million Series C Financing
Latham & Watkins represented SourceDay in the transaction. SourceDay, a leading supply chain procurement collaboration engine for direct spend materials and one of Austin’s fastest-growing companies,...